Revenue | ₹21.65Cr |
Net Profits | ₹0.58Cr |
Net Profit Margins | 2.68% |
Par Drugs & Chemicals Ltd’s revenue fell -10.65% since last year same period to ₹21.65Cr in the Q3 2024-2025. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated -39.3% fall in its revenue since last 3-months.
Par Drugs & Chemicals Ltd’s net profit fell -83.04% since last year same period to ₹0.58Cr in the Q3 2024-2025. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated -93.26% fall in its net profits since last 3-months.
Par Drugs & Chemicals Ltd’s net profit margin fell -81.02% since last year same period to 2.68% in the Q3 2024-2025. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated -88.89% fall in its net profit margins since last 3-months.
The revenue for Par Drugs & Chemicals Ltd in the Q3 results 2024 was ₹21.65Cr.
The net profit for Par Drugs & Chemicals Ltd in the Q3 results 2024 was ₹0.58Cr.
The net profit margin for Par Drugs & Chemicals Ltd in the Q3 results 2024 was 2.68%.
The revenue for Par Drugs & Chemicals Ltd in the Q3 results 2023 was ₹24.23Cr.
The net profit for Par Drugs & Chemicals Ltd in the Q3 results 2023 was ₹3.42Cr.
The net profit margin for Par Drugs & Chemicals Ltd in the Q3 results 2023 was 14.11%.